BioCentury | Oct 8, 2020
Product Development

COVAX nears $2B fund-raising goal for equitable vaccine distribution; plus Novartis-Merck KGaA, 10x Genomics, Alkermes, UCB-Aetion, Janpix, BeiGene-BioAtla, Phenomic AI

...Genomics acquires in situ analysis technologies10x Genomics Inc. (NASDAQ:TXG) will acquire in situ technology company ReadCoor Inc....
BioCentury | Apr 11, 2019
Targets & Mechanisms

A venture view of biological white space

...are becoming more accessible through established tools companies like Fluidigm Corp. and smaller startups like ReadCoor Inc....
...Therapeutics, Redwood City, Calif. NodThera Ltd., Little Chesterford, U.K. Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland ReadCoor Inc....
BioCentury | Oct 3, 2016
Financial News

ReadCoor completes venture financing

ReadCoor Inc. , Boston, Mass. Business: Genomics, High throughput screening Date completed: 2016-09-28 Type: Venture financing Raised: $23 million Investors: Decheng Capital; Lilly Asia Ventures; Vivo Capital; private investor WIR Staff...
BioCentury | Sep 29, 2016
Financial News

Harvard's Wyss launches gene imaging newco ReadCoor

...in situ analysis of gene expression. The FISSEQ platform was incubated within the Wyss Institute. ReadCoor...
...to academia and industry "almost immediately." Decheng's Victor Tong and Vivo's Yuh-geng Tsay will join ReadCoor's...
Items per page:
1 - 4 of 4
BioCentury | Oct 8, 2020
Product Development

COVAX nears $2B fund-raising goal for equitable vaccine distribution; plus Novartis-Merck KGaA, 10x Genomics, Alkermes, UCB-Aetion, Janpix, BeiGene-BioAtla, Phenomic AI

...Genomics acquires in situ analysis technologies10x Genomics Inc. (NASDAQ:TXG) will acquire in situ technology company ReadCoor Inc....
BioCentury | Apr 11, 2019
Targets & Mechanisms

A venture view of biological white space

...are becoming more accessible through established tools companies like Fluidigm Corp. and smaller startups like ReadCoor Inc....
...Therapeutics, Redwood City, Calif. NodThera Ltd., Little Chesterford, U.K. Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland ReadCoor Inc....
BioCentury | Oct 3, 2016
Financial News

ReadCoor completes venture financing

ReadCoor Inc. , Boston, Mass. Business: Genomics, High throughput screening Date completed: 2016-09-28 Type: Venture financing Raised: $23 million Investors: Decheng Capital; Lilly Asia Ventures; Vivo Capital; private investor WIR Staff...
BioCentury | Sep 29, 2016
Financial News

Harvard's Wyss launches gene imaging newco ReadCoor

...in situ analysis of gene expression. The FISSEQ platform was incubated within the Wyss Institute. ReadCoor...
...to academia and industry "almost immediately." Decheng's Victor Tong and Vivo's Yuh-geng Tsay will join ReadCoor's...
Items per page:
1 - 4 of 4